A Tumblr Takeover? ...
Health Care: Drugs
Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)
$3.04 0.04 | 1.33%
05/17/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| CYCC | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -45.45 | -10.22 | -80.52 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -90.10 | -0.92 | -0.57 |
| Net Income | -0.30 | 0.00 | |
| EPS | -0.73 | 0.00 |
Earnings for CYCC:
| EBITDA | -15.00 |
| REVENUE | 69.00K |
Average Earnings Estimates
| Qtr (12/12) | Qtr (03/13) | FY (12/12) | FY (12/13) | |
|---|---|---|---|---|
| Average Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Number of Analysts | 0 | 0 | 0 | 0 |
| High Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Low Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Prior Year | $-0.49 | $-0.42 | $-2.24 | $n.a. |
| Growth Rate (Year over Year) | n.a.% | n.a.% | n.a.% | n.a.% |
Portfolios with CYCC
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Uservlady 1
- Contributor13 Biotech Stocks Bought an...
- ProWilbur Ross - Invesco Priva...
- Contributor10 Cheap Biotech Stocks Tha...
- Userjeezlola
Latest CYCC Headlines from TheStreet
- Reminder: Cyclacel Pharmaceuticals' 6% Preferred Stock Goes Ex-Dividend Soon 04.16.13 | 01:04 pm
- Combination Potential Of Cyclacel's Sapacitabine And Seliciclib Reported At AACR 04.09.13 | 02:04 pm
- AACR Press Conference Highlights Combination Potential Of Two Cyclacel Drugs 04.08.13 | 07:04 am
- Cyclacel Announces Sale Of Four Cyclacel Romidepsin-Related Patents To Celgene And Dismissal Of All Claims In Their Patent Litigation 04.04.13 | 07:04 am
- Cyclacel Announces Multiple Abstracts Selected For Presentation At American Association For Cancer Research Annual Meeting 04.03.13 | 02:04 pm
- Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2012 Financial Results 03.27.13 | 04:03 pm
- 5 Stocks Set to Soar on Bullish Earnings 03.25.13 | 01:03 pm
- Cyclacel To Announce Year-End And Fourth Quarter 2012 Financial Results 03.22.13 | 07:03 am
- Cyclacel Announces Grants Of New U.S. & European Patents Covering Sapacitabine Used In Combination With HDAC Inhibitors 02.12.13 | 07:02 am
- Cyclacel Pharmaceuticals To Present At The 15th Annual BIO CEO & Investor Conference 02.04.13 | 07:02 am
Press Releases for CYCC
Partner Headlines for CYCC
- Cyclacel Pharma to Offer New Sapacitabine Data at ASH on Dec. 9th - Benzinga 12.04.12 | 09:12 am
- Upcoming AML Treatments - Which Company Will Fly? - Seeking Alpha 12.03.12 | 09:12 am
- 4 Cash Loaded Biotech Stocks With Little Debt - Seeking Alpha 08.30.12 | 09:08 am
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- The Biotech Bump: Cyclacel Pharmaceuticals - Benzinga 07.28.11 | 01:07 pm
- Profit From These 3 Analysts' Stock Picks for Under $10 - Seeking Alpha 07.13.11 | 09:07 am
